Litigation Details for CELGENE CORPORATION v. SYNTHON PHARMACEUTICALS, INC. (M.D.N.C. 2018)
✉ Email this page to a colleague
CELGENE CORPORATION v. SYNTHON PHARMACEUTICALS, INC. (M.D.N.C. 2018)
| Docket | ⤷ Sign Up | Date Filed | 2018-06-21 |
| Court | District Court, M.D. North Carolina | Date Terminated | 2018-07-25 |
| Cause | 35:271 Patent Infringement | Assigned To | Loretta Copeland Biggs |
| Jury Demand | None | Referred To | Joi Elizabeth Peake |
| Patents | 8,198,262; 8,673,939; 8,735,428; 8,828,427 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in CELGENE CORPORATION v. SYNTHON PHARMACEUTICALS, INC.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for CELGENE CORPORATION v. SYNTHON PHARMACEUTICALS, INC. (M.D.N.C. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2018-06-21 | 1 | Complaint | United States Patent Nos. 8,198,262 (the “’262 patent”), 8,673,939 (the “’939 patent”), 8,735,428 (the…262 Patent, # 2 Exhibit B - '939 Patent, # 3 Exhibit C - '428 Patent, # 4 Exhibit D - '427 Patent)(WOOTEN… 20 patent”), and 8,828,427 (the “’427 patent”), all owned by Celgene (collectively, “the patents-in-… 1. This is an action for patent infringement under the patent laws of the United States, 35 U.S.C… The Patents-in-Suit 7. On June 12, 2012, the United States Patent and Trademark | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
